Physician profile
Balaji P Athreya
NPI 1598745010
$1,016.76
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2021: $35.73 · 2023: $625 · 2024: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $316.78 | 2023-2024 | Renal - Pd |
| Amgen INC. | $167.80 | 2019-2023 | Tavneos |
| Calliditas Therapeutics US INC. | $125.00 | 2023 | Tarpeyo |
| Inspire Medical Systems, INC. | $124.99 | 2023 | Inspire |
| Horizon Therapeutics Plc | $124.91 | 2023 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $100.73 | 2019 | |
| Alnylam Pharmaceuticals INC. | $35.73 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $20.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Balaji Athreya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.